At the completion of this activity, the participant will be able to:
1. Review the components of the lethal triad and the effects it has on trauma patients
2. Discuss pharmacology and pharmacokinetics of tranexamic acid
3. Identify evidence-based treatment strategies of tranexamic acid in the trauma patient population
4. Identify evidence-based treatment strategies of tranexamic acid in patients with traumatic brain injury

Session date: 
11/15/2024 - 1:00pm to 2:00pm EST
Location: 
AGH Ambrose-Berg Room and Zoom Webinar
To Join the Zoom Webinar:
https://highmarkhealth.zoom.us/j/98672570454?pwd=VU80YWJYNjgraGVsQ0xkU2xSNWozQT09
Meeting ID: 986 7257 0454; Passcode: 877628
United States
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Attendance

Please login or register to take this course.